Pembrolizumab Plus Bevacizumab and Chemotherapy for Non-Squamous NSCLC Patients

NCT05751187 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Non-squamous NSCLC

Interventions

BIOLOGICAL: Pembrolizumab
BIOLOGICAL: Bevacizumab
DRUG: Pemetrexed
DRUG: Cisplatin
DRUG: Carboplatin
DIETARY_SUPPLEMENT: Folic acid 350-1000 μg
DIETARY_SUPPLEMENT: Vitamin B12 1000 μg
DRUG: Dexamethasone 4 mg

Sponsor

Shanghai Chest Hospital

Collaborators

[object Object]